| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |